Background: Delirium is common, distressing, serious and under-researched in specialist palliative care settings. Objectives: To examine whether people requiring palliative care were included in non-pharmacological delirium intervention studies in inpatient settings, how they were characterised and what their outcomes were. Design: Systematic review (PROSPERO 2017 CRD42017062178). Data sources: Systematic search in March 2017 for non-pharmacological delirium intervention studies in adult inpatients. Database search terms were 'delirium', 'hospitalisation', 'inpatient', 'palliative care', 'hospice', 'critical care' and 'geriatrics'. Scottish Intercollegiate Guidelines Network methodological checklists guided risk of bias assessment. Results: The 29 included studies were conducted between 1994 and 2015 in diverse settings in 15 countries (9136 participants, mean age = 76.5 years (SD = 8.1), 56% women). Most studies tested multicomponent interventions (n = 26) to prevent delirium (n = 19). Three-quarters of the 29 included studies (n = 22) excluded various groups of people requiring palliative care; however, inclusion criteria, participant diagnoses, illness severity and mortality indicated their presence in almost all studies (n = 26). Of these, 21 studies did not characterise participants requiring palliative care or report their specific outcomes (72%), four reported outcomes for older people with frailty, dementia, cancer and comorbidities, and one was explicitly focused on people receiving palliative care. Study heterogeneity and limitations precluded definitive determination of intervention effectiveness and only allowed interpretations of feasibility for people requiring palliative care. Acceptability outcomes (intervention adverse events and patients' subjective experience) were rarely reported overall. Conclusion: Non-pharmacological delirium interventions have frequently excluded and under-characterised people requiring palliative care and infrequently reported their outcomes.
Introduction
Delirium is a serious complication of medical illness and hospitalisation. 1 The condition is characterised by acute disturbances to attention, awareness and cognition; has multifactorial aetiology; and variously affects memory, language and visuospatial ability, orientation and perception. 2 Affected persons often experience feelings of fear, humiliation, confusion and disconnection from others. 3, 4 Family members' experience distress when delirium causes sudden changes in behaviour and decline in the person they love. 5, 6 Patients who experience an episode of delirium during hospitalisation experience many poorer outcomes, including being more likely to die. 1, 7, 8 Delirium most often occurs in people with older age, advanced or severe illness and/or pre-existing cognitive impairment. Hospital-wide, one in five patients have delirium, 9 with occurrence higher again in intensive, geriatric and palliative care units. 1, 6 Studies of delirium epidemiology in palliative care inpatient units that screened patients at least daily reported incidence of 33%-45% and prevalence of 58%-88% in those who died.
Development of delirium guidelines, 1,10-13 policy 14 and international advocacy 15 indicate growing awareness of the seriousness and prevalence of delirium and importance of evidence-based care for hospitalised patients. 16, 17 There now is sufficient evidence to implement non-pharmacological interventions for delirium in certain hospital settings. 18, 19 For example, reviews of studies of multicomponent interventions addressing physical and cognitive activity, sleep, hearing, vision and hydration, as in the original Hospital Elder Life Program (HELP) study, 20 reported reduction in incident delirium in older hospitalised patients. [21] [22] [23] Reduction in length of hospital stay and improvement in return to independent living were also demonstrated. 22 In contrast, guideline recommendations for non-pharmacological interventions as the first approach to prevent and treat delirium during advanced illness and at the end of life are not evidence based. 10, 17, 24 A recent scoping review reported the need to generate evidence to inform clinical care in palliative care settings and populations, for non-pharmacological interventions in particular. 25 Poorer outcomes with antipsychotics 26 and over-sedation when benzodiazepines were given for agitated delirium 27 in two recent trials in specialist palliative care settings also highlight the need to establish 'drug-free' ways to prevent and relieve the difficulties of delirium at the end of life.
In response, the authors established the 'Studies to Understand and Improve Delirium Care in Palliative Settings' international collaborative (SUNRISE) to generate high-quality delirium research in palliative care. We identified the need to inform our future trials in palliative care through a review of studies of non-pharmacological interventions for delirium conducted in a wide range of inpatient settings. This wide review was premised on our clinical experience and knowledge that many hospitalised patients have advanced and/or serious illness, frailty and high comorbidity and consequently much in common with patients in specialist palliative care settings, especially those in intensive care and medical and geriatric units where rates of delirium are similarly high. 28, 29 Based on this premise, our specific objectives were to examine whether people requiring palliative care were included in non-pharmacological delirium intervention studies in various inpatient settings, how these participants were characterised, and whether the non-pharmacological interventions were effective, feasible and/or acceptable for them.
Methods

Design
Systematic review of the literature, following the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA). 30 
What this paper adds?
• • This review found that various groups of people requiring palliative care were excluded from three-quarters of nonpharmacological delirium intervention studies in inpatient settings; despite this, they were present in most studies and their outcomes were reported in five. • • Non-pharmacological delirium interventions appear feasible for people requiring palliative care yet there is no definitive evidence they are effective or acceptable for this inpatient group.
Implications for practice, theory or policy
• • Phase II and phase III randomised controlled trials of non-pharmacological interventions to prevent and treat delirium are needed in specialist palliative care settings. • • Adaptations to future trials of non-pharmacological delirium interventions in other inpatient settings are needed to promote representative study populations and allow outcomes for subgroups of people requiring palliative care to be reported. • • Additional outcomes related to patient and family subjective experience, goals of care and quality of life would enhance the relevance of delirium intervention research in inpatient settings where people are cared for at the end of life.
Participants/settings
Adults (⩾18 years) receiving inpatient hospital or hospice care. In this review, we refer to 'hospice' as an inpatient facility with the primary function to provide specialist palliative care to people with life-threatening illness and analogous to a palliative care inpatient unit.
Search strategy
In 31 We tailored search terms and filters to subsequent databases. We examined reference lists of relevant systematic reviews and meta-analyses identified in the search for additional eligible studies.
Inclusion/exclusion criteria. Studies included were primary reports of prospective trials (i.e. studies of an intervention with a comparator); with a primary objective to prevent or treat delirium through non-pharmacological intervention/s in adult patients in hospital or hospice unit settings; a primary outcome of delirium incidence, severity or duration; published in English in a peer-reviewed journal. Studies excluded were reports of interventions for alcohol withdrawal delirium only; systematic reviews and metaanalyses of non-pharmacological delirium intervention/s; studies where the primary outcome was not participants' delirium status (e.g. process or cost-effectiveness outcomes, validation of delirium tools); studies that did not use diagnostic criteria or a tool with established psychometric properties to measure delirium; protocols; and ongoing studies.
Study selection, data extraction and management
We imported search results into Endnote X7 software, removed duplicates and exported results to Covidence, 32 where three reviewers (I.A.D., L.E. and A.H.) independently applied eligibility criteria to titles and abstracts. Reviewers compared decisions about inclusion, documented reasons for exclusions at full text review and resolved discrepancies through discussion. Two reviewers (I.A.D., L.E.) extracted data according to the template for intervention description and replication (TIDieR) checklist and guide 33 into an Excel V15.28 spreadsheet. The lead reviewer (A.H.) contributed guidance, oversight and independent data checking.
Risk of bias assessment
Two reviewers (L.E. and A.H.) independently assessed each study for selection, performance, detection, attrition, confounding and reporting biases according to the Scottish Intercollegiate Guidelines Network (SIGN) Methodology Checklists 34 for controlled trials and cohort studies. Discrepancies were resolved through discussion.
Outcomes
To identify our sample of interest (i.e. people requiring palliative care), we examined study inclusion and exclusion criteria, participant diagnoses (including severity or staging) and mortality. We assessed eligibility criteria and diagnoses against the Gold Standards Framework Proactive Identification Guidance (GSF PIG), a clinical tool to help identify people likely to need additional supportive (i.e. palliative) care in the last 12 months of life. 29 According to the GSF PIG, these people are those with life-threatening conditions, including illnesses that are advanced, progressive, incurable and/or likely to cause acute crises; frailty and comorbidities; and sudden catastrophic events.
Previous reviews have reported effectiveness outcomes of non-pharmacological delirium interventions for the entire study sample, [21] [22] [23] whereas this review focused on effectiveness, feasibility and acceptability outcomes of our sample of interest. We examined effectiveness according to each study's primary outcome and any subgroup analysis for our sample of interest. We assessed feasibility by examining intervention characteristics, adherence and study modifications, and acceptability through interventionrelated adverse effects and patient, family, clinician and volunteer subjective experiences of the interventions.
Synthesis and analysis plan
We generated tables, text and graphs to report study characteristics, participants, interventions and outcomes. Data transformation and descriptive numerical analyses were performed using Excel. We planned to perform subgroup meta-analysis using Review Manager Analyses software 35 of intervention effectiveness if we could definitively distinguish our sample of interest and if interventions and comparators and measures were comparable.
Updated search
We updated the search prior to publication in February 2019 and identified two new eligible papers published after the original search date. 36, 37 They were not incorporated as neither paper altered the conclusions of the review.
Results
The original database search strategy generated 4300 records. After removing 35 duplicates and 4169 records through title and abstract screening, we reviewed 69 full text papers and excluded 48. We included another eight through reference list searching, resulting in 29 papers reporting 29 studies for inclusion ( Figure 1 ).
Study characteristics
The 29 studies were conducted between 1994 and 2015 across 15 countries: six in the United States, 20, [38] [39] [40] [41] [42] three each in Australia, [43] [44] [45] Belgium, [46] [47] [48] and Canada, [49] [50] [51] two each in the Netherlands 52, 53 and Sweden, 54, 55 and one each in Chile, 56 France, 57 Ireland, 58 Italy, 59 Japan, 60 Korea, 61 Singapore, 62 Spain, 63 the United Kingdom, 64 and the United States/Canada 65 (Table 1) .
Study designs were before/after studies (one with an additional concurrent arm 62 ) (n = 11), [38] [39] [40] [41] 44, 45, 48, 52, 57, 62, 64 RCTs (n = 10), 42, 43, 47, 50, 51, 53, 55, 56, 61, 65 non-randomised controlled trials (one with matched participants 20 ) (n = 5), 20, 46, 54, 59 ,63 a quasi-experimental study, 49 a pilot randomised controlled trial 60 and a comparative time series study. 58 Services and settings were medical (n = 10), 20, 41, 43, [50] [51] [52] 54, 56, 59, 63 geriatric (n = 7), 39, 44, 55, 57, 59, 62, 63 medical and/or surgical intensive care (n = 6), 38, 40, 47, 58, 61, 64 perioperative hip fracture (n = 6), 42, 45, 46, 48, 55, 65 other perioperative (n = 3) 52, 53, 60 and palliative care and hospice units (n = 1), 49 with eight studies involving more than one service. 47, 52, 55, 58, 59, 61, 63, 64 Most studies tested multicomponent interventions (n = 26) and aimed to prevent delirium in non-delirious participants (n = 19) ( Table 1) . Six studies aimed to prevent and treat delirium, 38, 42, 48, 54, 55, 65 three were treatment only studies. 50, 51, 62 
Risk of bias assessment
Almost all studies were assessed as having at least one form of selection bias (n = 28). The exception was a Chilean RCT of a prevention intervention where family members delivered cognition, vision and hearing strategies to patients. 56 Eight RCTs minimised internal selection bias through concealed allocation and random sequence generation. 42, 43, 47, 50, 53, 55, 56, 65 There was high risk of performance bias in all studies, due to the inherent difficulty of blinding non-pharmacological interventions: one RCT blinded participants to their allocation, 43 and no studies blinded those performing the intervention. Detection bias was minimised in eight studies through blinded outcome assessors combined with valid, reliable delirium measures. 42, 43, 47, 50, 51, [53] [54] [55] Although we excluded studies that did not use delirium diagnostic criteria and/or a tool with established psychometric properties, three studies were assigned uncertain risk of detection bias due to retrospective assignment of delirium status when the Confusion Assessment Method (CAM) was not performed during weekends in two before-after studies 41, 45 and when delirium incidence was reported as a mean rather than a proportion in a comparative time series study. 58 High risk of detection bias was assigned to a delirium prevention study in seven Canadian palliative care units due to use of a screening tool, the Confusion Rating Scale (CRS) to measure delirium incidence, severity and duration. 49 Six studies had low risk of attrition bias. 42, 43, 50, 55, 56, 63 Confounders were accounted for in 17 studies. 20, 39, 40, 42, 46, 47, [49] [50] [51] [52] 54, 55, 58, 59, 61, 63, 65 Most studies (n = 22) reported only a priori outcomes, 20, [38] [39] [40] [41] [42] [43] 46, 48, [50] [51] [52] [53] [55] [56] [57] [60] [61] [62] [63] [64] [65] which we assessed by information provided within the papers rather than through examination of trial registrations or published protocols, which no studies cited. Figure 2 presents overall risk of bias in the included studies.
Participant characteristics
There were 9136 participants (n = 4553 in intervention arms) across the 29 studies (Table 2 ). Sample sizes ranged from 15 to 1516 participants. Participants' overall mean age (excluding two studies that reported only age range or median) 48 ,58 was 76.5 years (SD = ±8.1). There were more female participants (56%) than male. Kamdar et al. 40 The United States P BA Medical ICU, tertiary academic hospital
Zaubler et al. 41 The United States P BA 38-bed general medical floor, 600-bed teaching community hospital
Andro et al. 57 France P BA Acute geriatric care unit M 6,10 Deschodt et al. 46 Belgium P CT Perioperative hip fracture in two trauma wards, university hospital
Gagnon et al. 49 Canada P QE Four hospital palliative care units + three stand-alone hospices
Martinez et al. 56 Chile P RCT Internal medicine ward in an acute hospital M 1,2,3,6,7,8,10
Van Rompaey et al. 47 Belgium P RCT 45-bed medical/surgical/cardiac surgical ICU, 625-bed university hospital S 2,3,5,6,9
Black et al. 58 Ireland P CTS Seven-bed medical and surgical ICU, inner city public hospital M 9
Bo et al. 59 Italy P CT Medical and geriatric units, university teaching hospital
Vidan et al. 63 Spain P CT Geriatric and internal medicine units, large public university hospital 
Inclusion and exclusion criteria
Inclusion. Most studies (n = 19) included only patients aged 65 years and older (Table 2) . Twenty-two studies included consecutively admitted patients, 16 of which further required certain physical conditions to be present (e.g. frailty, 53 hip fracture, 42, 45, 46, 48, 55, 65 anaemia, 65 dementia, 57 advanced cancer, 49 oesophageal cancer surgery 60 ). Five studies included only patients with risk factors for delirium 20, 44, 52, 56, 63 and three included only patients with delirium. 50, 51, 62 The study in seven Canadian palliative care units (hereafter termed the 'palliative care unit study') included only patients with terminal cancer, defined as dying within 90 days of admission which was retrospectively identified. This study had the largest sample of all the studies (n = 1516, 17%). 49 Exclusion. Twenty-three studies excluded patients on various diagnostic grounds (Table 2) . These were stroke or cerebrovascular accident (CVA), moderate-severe traumatic brain injury or coma (n = 9) 20, 38, 43, 48, 50, 51, 59, 62, 63 ; dementia or prior cognitive impairment (n = 7) 20, 38, 44, 47, 61, 63, 64 ; psychiatric disorders or alcohol/drug addiction (n = 6) 43, 44, [59] [60] [61] 64 ; pathological fracture (n = 4) 46, 48, 55, 65 ; poly-or multiple trauma (n = 2) 46,48 ; neurologic diagnosis/neurosurgical (n = 2) 61,64 ; metastatic cancer or referred to oncology services (n = 2) 42,50 ; and others (myocardial infarction, 65 severe renal failure, 55 brain concussion, 48 history of sleep pathology, 64 severe rheumatoid arthritis 55 and severe hip osteoarthritis 55 ).
Fifteen studies excluded patients with impaired verbal communication or who were otherwise unable to complete study assessments. 20, 38, 39, 41, 43, 46, 48, 50, 52, 53, 59, [61] [62] [63] 65 Six studies excluded patients with hearing and/or visual impairment. [46] [47] [48] 60, 61, 64 Three studies excluded patients isolated for infection. 43, 61, 62 Eight studies explicitly excluded patients expected to die, using the following terms: 'terminal diagnosis' or 'terminal illness' (n = 3), 20, 58, 62 'terminal condition and receiving comfort care' (on the basis that they were unlikely to benefit from the intervention) (n = 2), 41, 44 'life expectancy less than six months', 46 'metastatic cancer or comorbid illnesses likely to reduce life expectancy to less than six Inouye et al. 20 The months', 42 'death expected within 24 hours' 43 and 'dangerously ill'. 62 Two studies excluded participants who subsequently died from analysis 51, 52 ; a delirium prevention study in elderly care wards excluded 70% of 2162 admitted patients due to being 'too unwell' 39 ; and another study excluded patients with 'deterioration of condition'. 60 The palliative care unit study excluded patients who lived for more than 90 days or who were still alive at discharge from analysis. 49 
Characterisation of study participants
Participant diagnoses and illness severity. Reporting of participant diagnoses, illness severity and mortality varied. Fifteen studies reported comorbid diagnoses, 12 reported only primary diagnoses and four reported both (Table 2) . Diagnoses' categorisation varied. Studies rarely reported staging of diagnoses (n = 2). 49, 56 Sixteen studies reported illness severity for all participants using at least one measure, more often as a mean or median score (n = 15) 20, 38, 43, 46, 47, 50, 52, 55, 56, 59, [61] [62] [63] [64] [65] than by categorising participants proportionally (n = 6). 20, 39, 42, 47, 52, 62 The most frequently used illness severity measures were the Charlson Comorbidity Index (CCI) 66 67 (n = 6; mean scores 11.3-15.6). 20, 43, 59, 61, 63, 64 Two ICU studies that measured illness severity using the APACHE II reported means scores (13.9-14.6) 61,64 approximately equivalent to or less than those reported in three of four medical and geriatric unit studies (14.1-15.6). 20, 43, 59 Other measures were the Cumulative Illness Rating Scale-Geriatrics (CIRS-G) comorbidity and severity indexes 52, 59, 68 ; American Society of Anesthesiologists physical status classification (ASA) 52 47, 73 ; Simplified Acute Physiology Score (SAPS 3) 47, 74 ; and the 15-item Geriatric Depression Scale (GDS-15). 55, 75 Three studies reporting comorbidities without the CCI reported (1) 60% had more than two comorbidities (diabetes, COPD, hypertension, myocardial infarction, other cardiovascular disorders, neurological disorders, cerebrovascular disorders, hearing and vision problems, memory problems in daily life, psychiatric disorders or musculoskeletal disorders), 53 (2) 72% had at least one comorbid illness 47 and (3) a mean of 2.7 comorbidities. 63 Almost every diagnosis, sensory deficit and impairment that were exclusion criteria in some studies were reported in the overall study population ( Table 2 ). For example, more studies reported participants with dementia or cognitive impairment (n = 13) 39, [41] [42] [43] 46, [48] [49] [50] [51] [55] [56] [57] 65 than excluded people with these conditions (n = 7). 20, 38, 44, 47, 61, 63, 64 Participant mortality. Mortality was reported in 19 studies at nine different time points, ranging from 'in the ICU' 38, 40 to 1-year post intervention. 46, 55, 62 In these studies, 2090 participants died (23%). Mortality rates ranged from 1% in three studies 20, 47, 61 to 100% in the palliative care unit study. 49 There were 596 participant deaths in 18 studies reporting mortality that were conducted outside of a specialist palliative care setting (12%). High mortality was reported for intervention and control medical unit participants at 8 weeks (22.1% vs 19.37%, 50 33% vs 37% for delirious patients 51 ) and at 6 months (33.8% vs 30.9%), 39 and at 1 year for older (⩾65) traumatic hip-fracture patients (33% vs 22%). 46 Six of the 19 studies measuring mortality excluded patients expected to die; despite this exclusion criteria, 134 participants of these six studies subsequently died during the study period (12%). 20, 44, 46, 52, 58, 62 Fifteen studies reported 21 comparative mortality rates, 20, [38] [39] [40] 45, 46, [50] [51] [52] [53] [54] [55] [61] [62] [63] only two of which reported significantly less mortality in intervention cohorts compared to controls, 54, 61 with one (at day 7 in hospital) not sustained at 30 days in hospital. 61 
Study approaches to people requiring palliative care
By examination of these data, we identified only one study that explicitly reported outcomes for participants requiring palliative care (n = 1). 49 Using the GSF PIG, we identified another four studies that reported primary or subgroup effectiveness outcomes for older people likely to require palliative care due to the presence of frailty, dementia, cancer and comorbidity. 42, 52, 53, 57 All five studies were of interventions to prevent delirium. Twenty-two studies either explicitly or resultantly excluded groups of people requiring palliative care (76%). 20, 38, 39, [41] [42] [43] [44] [46] [47] [48] [50] [51] [52] 55, [58] [59] [60] [61] [62] [63] [64] [65] Yet, through our interpretation of reported diagnoses, levels of comorbidity, frailty and mortality (signified with 52 C, E, S, N, L, K, CA ✓ Nurses, physicians, trained volunteers, with training delivered by geriatric team Bryczkowski et al. 38 P, S, F, D, J, K, PE ✓ Whole team, research staff, family Chong et al. 62 C, E, H, V, P, W, G, J NR Trained geriatric nurses, cognitive assessment by consultant geriatrician O/A Patel et al. 64 C, E, P, S, D, Pa, J, K ✓ Physicians, nurses, PT, senior staff acting as champions Gruber-Baldini et al. 65 T (blood transfusion) ✓ NR Hempenius et al. 53 C, E, H, V, N, CA ✓ Consultant geriatricians and geriatric nurses Holt t al. 39 C, E, H, V, S, Pa, B NR Specialist nurse, consultant geriatrician, nurse manager, ward staff Jeffs et al. 43 C, E ✓ Allied health assistant, PT Kamdar et al. 40 P, S, J, K ✓ Bedside staff Zaubler et al. 41 C, H, V, P, W, S, N, K ✓ Elder Life Specialists, volunteers Andro et al. 57 C, J NR NR Deschodt et al. 46 G, CA ✓ Consultative geriatrician, nurse, social worker, occupational therapist, physiotherapist, bedside staff Gagnon et al. 49 C, F, K ✓ Bedside and research nurses, physicians Martinez et al. 56 C, H, V, F ✓ Family members with education by researchers Van Rompaey et al. 47 P (earplugs) ✗ Nurses Black et al. 58 F ✓ Nurses, family Bo et al. 59 C, E, P, W, S, F, N, Pa, K ✓ Physicians, nurses, PT Vidan et al. 63 C, E, H, V, P, V, W, S, N ✓ Geriatricians, residents, nurses (including a fulltime specialist geriatric nurse) Caplan and Harper 44 C, H, V, W, N ✓ Volunteers, volunteer coordinator Lundström et al. 55 E, P, W, S, N, Pa, O, L, G, B, K, CA, Z, Ph ✓ Nurses, PT, OT, dietician, geriatricians; liaison with orthopaedic surgeons, geriatricians and community colleagues for post-hospital care Taguchi et al. 60 J (bright light) ✓ NR Lundström et al. 54 S, F, G ✓ All ward staff Wong et al. 45 C, E, H, V, P, W, F, N, D, Pa, O, B, J, Z, K ✓ Geriatric registrar, geriatric team, nurses, nursing assistants, anaesthetist, pharmacist Cole et al. 50 C, E, H, V, F, G, J, CA ✓ Geriatric internist, geriatric psychiatrist, study nurse, bedside nurses Marcantonio et al. 42 C, E, H, V, W, N, D, Pa, O, G, B, J, CA, Z, K ✓ Geriatrician consulting to orthopaedics team Milisen et al. 48 S, Pa, G, K NR Nurses Inouye et al. 20 C, E, H, V, P, W ✓ A geriatric nurse, therapeutic-recreation and two Elder Life Specialists, PT, geriatrician, volunteers Cole et al. 51 C, E, H, V, F, J, CA ✓ Geriatrician, geriatric psychiatrist, liaison nurse superscript 'c' in Table 2 ), we also identified that people requiring palliative care were present in 21 studies that did not specifically characterise them or report their outcomes (72% Figure 3 presents these findings diagrammatically.
Effectiveness outcomes for people requiring palliative care
Overall, 20 studies reported that the intervention was effective according to at least one primary outcome (69%). 20, [38] [39] [40] [41] [42] [44] [45] [46] 51, [54] [55] [56] [57] [59] [60] [61] [62] [63] [64] The one study explicitly focused on preventing delirium in people receiving palliative care (patients with terminal cancer) tested three primarily nurse-delivered intervention components for orientation, informing family and assessment of medication risk factors plus querying physicians about changes to medication and found no statistically significant difference in delirium incidence (p = 0.66, odds ratio (OR) = 0.94), severity or duration between intervention and control sites. 49 Outcomes of four participant groups that we identified as requiring palliative care were as follows:
A delirium prevention RCT of a geriatric liaison intervention of comprehensive assessment, cognitive and physical activity, hearing, vision and nutrition for frail elderly cancer patients undergoing surgery for a solid tumour reported no significant difference between delirium incidence in intervention and control groups (9.4% vs 14.3%, OR = 0.63, 95% confidence interval = 0.29-1.35). 53 A delirium prevention RCT of geriatric consultation and multiple care components (Table 3) performed analysis for the subgroup pf people with dementia within a perioperative hip-fracture population, reporting a nonstatistically significant reduction in delirium incidence in the intervention group compared with control (n = 13 (62%) vs n = 20 (69%), p = 0.6). 42 A delirium prevention before-after study of orientation and communication strategies for patients with dementia in a French acute geriatric unit reported a 66% relative risk reduction of delirium in the after cohort (RRR = 0.34, 95% confidence interval = 0.15-0.78). 57 A delirium prevention before-after study of delirium/ cognitive screening, comprehensive assessment, cognitive and physical activity, nutrition, falls prevention, medication review and staff education in frail elderly surgical patients found no statistically significant difference in incidence of delirium (11% vs 10%, p = 0.945) or cognitive decline (15% vs 12%, p = 0.431) in the before group compared with the after group. 52 Due to heterogeneity of study interventions and measures (Table 2) , we did not conduct meta-analysis of these effectiveness outcomes.
Types of outcomes measured in the included studies
Twenty-nine different outcomes were measured overall (Figure 4 ). There were nine different primary outcomes, the most frequent was delirium incidence (n = 21). 20, 38, 39, [41] [42] [43] [44] [45] [46] 48, 49, 52, 53, [56] [57] [58] [59] [60] [61] 63, 64 Of the 22 different secondary outcomes, the most often reported was length of ICU or hospital stay (n = 16). [38] [39] [40] [41] [42] [43] 45, 46, 48, 50, 51, [53] [54] [55] [56] 62 Feasibility outcomes
Intervention components
The interventions consisted of 24 components overall, varying in type and number per study (1-15) (M = 6.3, SD ± 4) ( Table 3 ). The type and number of strategies in each component also varied (data not reported here).
Eighteen multicomponent prevention interventions most often included strategies for cognitive activity (n = 15) 20, 39, 41, [43] [44] [45] 49, 52, 53, 56, 57, 59, 61, 63, 64 ; physical activity (n = 9 ) 20, 39, 43, 45, 52, 53, 59, 63, 64 ; hearing (n = 9) 20, 39, 41, 44, 45, 53, 56, 61, 63 ; vision (n = 9) 20, 39, 41, 44, 45, 53, 56, 61, 63 ; sleep-wake cycle preservation (n = 8) 20, 40, 41, 45, 59, 61, 63, 64 ; nutrition (n = 8) 41, 44, 45, 52, 53, 59, 61, 63 ; staff education [39] [40] [41] 52, 59, 61, 63, 64 ; and hydration (n = 7). 20, 41, 44, 45, 59, 61, 63 These components largely correspond to those of the original HELP study. 20 Components of six delirium prevention and treatment interventions were more diverse (M = 8), with staff education (n = 4), 38, 48, 54, 55 staff changes (n = 3) 48, 54, 55 and strategies for pain (n = 3) most often included. 42, 48, 55 The most common components of three delirium treatment interventions were cognitive activity (n = 3), 50, 51, 62 physical activity (n = 3), 50, 51, 62 hearing (n = 3), 50, 51, 62 vision (n = 3), 50, 51, 62 sleep-wake cycle preservation (n = 2) 50,62 and environmental changes (e.g. adjustments to lighting and noise) (n = 2). 51, 62 Overall, multicomponent interventions also often included family involvement (e.g. information/education about delirium, increased family presence) (n = 9), 38, 45, [49] [50] [51] 56, 58, 59, 61 environmental strategies (n = 9) 38,40,42,45,50,51,61,62 ,64 and comprehensive assessment (n = 8). 42, 46, [50] [51] [52] [53] 55, 61 Pharmacological strategies (e.g. medication reviews and alerts, protocols for pain and sedation strategies) were present in half of the multicomponent interventions (n = 12). 38, [40] [41] [42] 45, 48, 49, 52, 55, 59, 61, 64 The three single component interventions were blood transfusion, 65 bright light therapy 60 and earplugs at night. 47 The five studies that reported effectiveness outcomes for our sample of interest addressed cognitive activity, 42, 49, 52, 53, 57 physical activity, 42, 52, 53 comprehensive assessment, 42, 52, 53 hearing, 42, 53 vision, 42, 53 nutrition, 42, 52, 53 pharmacological strategies, 42, 49, 52 environmental strategies, 42, 57 family involvement, 49 staff changes, 42 pain, 42 medical complications, 42 oxygen, 42 staff education, 52 falls prevention, 52 delirium/cognitive screening 52 and bladder/ bowel function 42 ( Figure 5 ).
Intervention delivery
Specialist geriatric clinicians or teams led almost half of the interventions, as either consultants or directly (n = 12). 20, 39, 42, 45, 46, [50] [51] [52] [53] 55, 62, 63 Interventions were delivered by interdisciplinary teams (n = 5) 20, 38, 45, 46, 55 ; physicians and nurses (n = 3) [49] [50] [51] ; nurses alone (n = 3) 47, 48, 61 ; physician, nurse and physiotherapists (n = 2) 59, 64 ; family members (n = 2) 56, 58 ; and physiotherapists and allied health assistants (n = 1). 43 Volunteers delivered part or all of the intervention in four studies. 20, 41, 44, 52 Three studies did not report who delivered the intervention, including two single-component interventions. 57, 60, 65 Most studies (n = 25) wholly or partly tailored components and strategies to patients' individual needs (Table 3) .
Adherence
Eighteen studies reported adherence to intervention strategies, using different methods and levels of detail (Supplementary Table 1 ). Almost all reported less than 100% adherence, with the exception reporting 100% geriatric nurse compliance with the 'semi-structured protocol'. 62 The palliative care unit study reported 89.7% overall adherence to the study protocol. 49 Three studies compared adherence to intervention strategies with that for control participants and reported that usual care sometimes mirrored some intervention strategies. 46, 50, 55 Two studies reported reasons for non-adherence: pharmacological sedation, coma and absence of a relative in the palliative care unit study, 49 and patient refusal or unavailability, staff member unavailability and medical contra-indications in the original HELP study. 20 
Study modifications
Two studies modified the intervention in the pilot phase, including changes in staff education and practice change materials, 39 and providing study information to family on admission rather than waiting until the researcher was present. 58 The palliative care unit study modified the primary outcome measure by not substituting the CRS for the CAM, due to CAM completion delays and poor completion rates (39% of participants) caused by 'the challenge of conducting the baseline CAM structured interview in the last days or hours of life'. 49 
Acceptability outcomes
Adverse effects
No study reported systematic processes of attribution of adverse effects to the intervention. Ten studies reported adverse events related to hospitalisation rather than the intervention 38, 44, [51] [52] [53] 55, 56, 62, 63 (Figure 4 and Supplementary  Table 2 ). No study reported statistically significant increased adverse events for intervention participants. Two simply stated that the intervention had no adverse effects. 20, 43 A RCT, 55 a controlled trial 63 and a before-after study 62 reported statistically significant reductions in some adverse events for intervention participants: falls, 55 physical restraint, 62, 63 pressure ulcers, 55,62 infection 55,62 and sleeping problems. 55 
Patient, family, clinician and volunteer subjective experiences
No study reported patients' subjective experiences of intervention (Supplementary Table 3 ). A survey of family caregiver's satisfaction with intervention and care for delirious patients within one study found most experienced moderate to high levels of distress (72%), believed that the environment and intervention helped the patient's recovery (86.6% and 83.5%, respectively) and that the three most useful strategies were activity, reality orientation and thrice-daily mobilisation. 62 A before-after study of older medical and surgical inpatients interviewed patients, volunteers, nurses and physicians and analysed meeting minutes to assess intervention integration in clinical practice, with minimal details of analysis methods and findings provided. 52 Four studies reported multidisciplinary and expert input during intervention development. 39, 40, 45, 61 The RCT of nocte earplugs in the ICU stated in the discussion that some participants preferred not to use them in order to remain 'in direct contact with their environment'. 47 No studies reported measures of patient distress related to delirium ( Figure 5 ).
Discussion
This review found that studies of non-pharmacological delirium interventions frequently excluded and under-characterised people requiring palliative care and subsequently their outcomes were infrequently reported. The likely reasons for these findings and how to address barriers to inclusion and report characteristics and outcomes for this patient subgroup in future research are discussed.
With regard to inclusion, this review identified a selection bias against people requiring palliative care through exclusion of people expected to die (using various prognoses and terminology) and also of those with greater acuity or severity of illness, particular diagnoses and with cognitive, sensory and/or communication impairments. These exclusions were rarely explained or justified and often seemingly arbitrary. Nor were they consistent across the studies. These exclusions represented people highly at risk of delirium. 1, 6 This finding reflects those of other reviews that identified selection biases against people with dementia in geriatric research 76 and older people from clinical trials in oncology. 77 Reasons for the exclusions identified in our review are likely to be multifactorial. One factor may be assumptions that the interventions were not appropriate, possible or likely to be effective for people requiring palliative care, as indicated by the two studies which justified the exclusion of patients with a terminal condition and requiring comfort care as that the intervention would be unlikely to benefit them. 41, 44 Historical views that people requiring palliative care are separate from the wider hospital population, rather than universally and always within it, may also have influenced some exclusion decisions. 78, 79 There are also pragmatic challenges to ensuring informed consent and completion of study measures when patients are frail, expected to decline, and have pre-existing cognitive and sensory impairments. However, these challenges may be overcome through a variety of research strategies, such as proxy, opt out and advance consent methods, early contact, tailoring of interventions and messaging to patients and family, adequate research resources and governance, and cluster designs. 26, 27, 80, 81 Outcomes such as days alive without delirium or coma may promote the inclusion of more severely ill patients in future delirium research, because consciousness is prerequisite for delirium measurement. 40, 82 Brief and observational delirium diagnostic tools that can be validly used with patients with cognitive, sensory and communication impairment are also available. [83] [84] [85] [86] Despite most studies excluding certain groups of people likely to require palliative care, unsurprisingly we identified that they were indeed present, despite under-reporting of their characteristics and outcomes. One reason it was difficult to retrospectively distinguish this subgroup for the purposes of ascertaining their outcomes in this review was that the studies reported participants' diagnoses, illness severity and mortality using different measures, time points, methods and degrees of detail. While identifying inpatients with palliative care needs in hospital is challenging and an uncertain science, both retrospectively and prospectively, there are ways it can be achieved. 29, [87] [88] [89] In addition to the GSF PIG which we applied in this review, 29 the Palliative Care Needs Assessment Tool 90 and the Supportive and Palliative Care Indicators Tool (SPICT) 91 can be used to identify which patients are at risk of deteriorating and dying in hospital. Other studies suggest identifying patients with palliative care needs through the presence of life-threatening illness coupled with receipt and acceptance of care focused on supporting quality of life, 87 or retrospectively through the use of death registration data. 89 Such methods could be used in delirium intervention research in settings where mortality is high, such as intensive care units, where existing illness severity measures focus on acuity and intensity of intervention and, despite having some prognostic utility, were never designed to identify a patient's need for palliative care. 67, 74, 92 Better characterisation of people requiring palliative care in studies of non-pharmacological interventions for delirium would help to build evidence of their outcomes in two ways.
First, it would allow subgroup analysis to be performed and reported in future studies in any setting. This is important because the question of whether delirium can be prevented and treated through non-pharmacological means was not definitively determined for this population by this review. The multi-site palliative care unit study had the greatest number of participants and reported good overall adherence to the study protocol 49 ; however, the only core care domain 21 was cognitive activity, consisting of nurses orientating patients to time, person and place each shift. Planned use of the CAM was not accomplished and the substituted screening tool 93 was not a validated tool for delirium diagnosis or severity. All participants had 'terminal' cancer and died within 90 days of admission and thereby were not fully representative of people requiring inpatient palliative care, including in specialist units, 49 not all of whom will die within 3 months. Only one geriatric unit study of people with dementia reported reduced delirium incidence; however, the report lacked detail, including of analysis methods. 57 The remaining three studies were focused on frail elderly patients with cancer, dementia, hip fracture and comorbidity following surgery, 42,52,53 a level of intervention and delirium risk that many people requiring palliative care would not undergo. Finally, we found no studies focused on non-pharmacological interventions to treat delirium in people requiring palliative care, highlighting the particular need to research this challenging area of clinical care.
Second, better recognition of people requiring palliative care in delirium research would heighten awareness of their needs, which in turn would instigate consideration of outcomes that are most meaningful to them. Reducing delirium incidence, duration and severity, length of admission and mortality were the foci of the included studies. While worthwhile aims at any point in the illness trajectory, more person-centred outcomes, such as reduction of delirium-related distress, and improved patient and family caregiver experiences of decision making, respect and dignity, and quality of life, were almost completely absent. 5, 94 Measuring these additional outcomes, which are highly valued by patients and family caregivers, 95, 96 would enrich this field of research and is achievable through both quantitative and qualitative methods. Adverse effects of intervention will also be important to systematically measure in future trials, given that patients with cognitive impairment have increased vulnerability to harm in hospital. 97 Finally, this review allowed an interpretation that many intervention components are feasible for people requiring palliative care by virtue of their delivery to elderly, frail and/or critically ill patients with and without delirium in the included studies. However, we suggest that studies measuring the feasibility of components of the original HELP intervention 20 that were subsequently found to be effective for other older hospitalised patients, that is, those targeting cognitive and physical activity, sleep, hearing, vision and hydration, [21] [22] [23] are necessary next steps within delirium research programmes in specialist palliative care settings. Limitations and strengths. A limitation of this review was that only English language studies were included. Another limitation was that our retrospective identification of people requiring palliative care was not sufficient to definitively determine outcomes for this patient subgroup; therefore, this review makes only recommendations for future research, not clinical practice. A strength of this review was our systematic approach adhering to PRISMA. 30 
Conclusion
This review found that studies of non-pharmacological delirium interventions have excluded poorly characterised and infrequently reported outcomes for people requiring palliative care. Based on these findings, we suggest new approaches to generate evidence for delirium interventions in this important patient subgroup. First, randomised controlled trials of non-pharmacological interventions to prevent and treat delirium are needed in specialist palliative care settings, with feasibility studies required before trials of effectiveness. Interventions should be based on those implemented and proven effective for older patients, especially those who were frail and severely ill with comorbidity. Second, broad inclusion criteria, justified exclusions and tailoring in future inpatient trials of non-pharmacological delirium interventions would promote representative study populations. Third, systematic characterisation of the subgroups of people requiring palliative care would allow their specific outcomes to be reported. Last, additional outcomes related to patient and family subjective experience, goals of care and quality of life would enhance the relevance of delirium research in inpatient settings where people are cared for at the end of life.
